Tabula Rasa HealthCare Inc. (NASDAQ:TRHC) finished Wednesday with a subtraction of -$0.02 to close at $10.22, a downside of -0.20 percent. An average of 1,678,820 shares of common stock have been traded in the last five days. There was a gain of $2.44 in the past week, and it reached a new high 17 times over the past 12 months. The last 20 days have seen an average of 484,190 shares traded, while the 50-day average volume stands at 308,456.
TRHC stock has increased by 18.42% in the last month. The company shares reached their 1-month lowest point of $7.50 on 08/03/23. With the stock rallying to its 52-week high on 08/07/23, shares of the company touched a low of $3.15 and a high of $10.37 in 52 weeks. It has reached a new high 16 times so far this year and achieved 106.46% or $5.27 in price. In spite of this, the price is down -1.45% from the 52-week high.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
Insider Transactions
TRHC stock investors should be aware that Tabula Rasa HealthCare Inc. (TRHC) stock had its last reported insider trading activity 244 days ago on Dec 12.
Valuation Metrics
Tabula Rasa HealthCare Inc. (TRHC) stock’s beta is 1.60. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 0.86.
Financial Health
The quick ratio of Tabula Rasa HealthCare Inc. for the recent quarter was 1.60, and the current ratio was 1.70, indicating that the company is able to meet its debt obligations. Tabula Rasa HealthCare Inc.’s EBITDA margin is -9.33%, while its operating margin for the same period stands at -17.80%. Its gross profit as reported stood at $66.91 million compared to revenue of $299.52 million.
For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, Tabula Rasa HealthCare Inc.’s return on assets was -33.20%.
Earnings Surprise
For the recent quarter, Tabula Rasa HealthCare Inc. had $232.6 million in total debt. In the quarter under review, the net income was up than the previous quarter. The company posted a net income of -$9.85 million in the quarter, while revenues of -$15.9 million were shrunk -403.65%. At the end of the recent quarter, Tabula Rasa HealthCare Inc.’s stock balance sheet showed total liabilities of 434.02 million. Shareholders own equity worth $27.05 million.
Technical Picture
From a technical analysis perspective, let’s take a brief look at Tabula Rasa HealthCare Inc. (TRHC) price momentum. RSI 9-day as of the close on 09 August was 77.35%, suggesting the stock is Overbought, with historical volatility in this time frame at 131.44%.
As of today, TRHC’s price is $9.28 +31.36% or $2.44 from its 5-day moving average. TRHC is currently trading +21.23% higher than its 20-day SMA and +78.36% higher than its 100-day SMA. However, the stock’s current price level is +92.47% above the SMA50 and +164.77% above the SMA200.
The stochastic %K and %D were 95.01% and 70.56%, respectively, and the average true range (ATR) was 0.58. With the 14-day stochastic at 94.77% and the average true range at 0.57, the RSI (14) stands at 72.06%. The stock has reached 1.58 on the 9-day MACD Oscillator while the 14-day reading was at 1.74.
Analyst Ratings
SVB Securities upgraded Tabula Rasa HealthCare Inc. (NASDAQ: TRHC) to a an Outperform rating in its most recent analyst report. Previously, the stock was rated as a Market perform. The consensus rating for Tabula Rasa HealthCare Inc. (TRHC) among analysts is Hold. According to current brokerage recommendations, 0 brokerage firms advise that investors sell TRHC, while 4 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 0 analysts, while 1 others rate it as a “buy”.
What is TRHC’s price target for the next 12 months?
Analysts predict a range of price targets between $10.00 and $11.00, with a median target of $10.50. Taking a look at these predictions, the average price target given by analysts for Tabula Rasa HealthCare Inc. (TRHC) stock is $10.50.
